Hogan & Hartson
rfleibenluft@hhlaw.com

PHONE
+1.202.637.5789

FAX
+1.202.637.5910

Export to WordPrint PageEmail Page
Robert F. Leibenluft
Partner, Washington, D.C.

Bob Leibenluft's practice is devoted entirely to health and antitrust matters, including counseling and litigation regarding antitrust issues in the health, medical device, and pharmaceutical industries.

Upon completing law school, Bob worked as an attorney advisor in the Federal Trade Commission (FTC)'s Office of Policy Planning, concentrating on health and antitrust matters. In 1981, he joined Hogan & Hartson and became a partner in the firm in 1989. He practiced health law at Hogan & Hartson until January 1996 when he rejoined the FTC as Assistant Director for Health Care in the FTC’s Bureau of Competition. As head of the Health Care Division, Bob supervised a 25-30 person staff engaged in the review of mergers, acquisitions, and joint ventures involving hospitals, physicians, and other health care providers, as well as conduct in the health care and pharmaceutical industries. He rejoined Hogan & Hartson again in September 1998.

Bob writes and lectures extensively on health law topics. His articles on health care matters have appeared in Health Affairs, The New England Journal of Medicine, Vanderbilt Law Review, The American Journal of Psychiatry, Business and Health, Pharmaceutical Executive, Medical Device & Diagnostic Industry, and other books and journals.

Hogan & Hartson Publications
11.25.2008 "Issue Eleven." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP

08.12.2008 "Issue Ten." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP

04.09.2008 "Issue Nine." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP

03.25.2008 "Antitrust & Pharmaceuticals: U.S. and EU Authorities Focus Attention on Competition in Pharmaceutical Industry." Pharmaceutical and Biotechnology Update, Hogan & Hartson LLP

03.25.2008 "Antitrust & Pharmaceuticals: U.S. and EU Authorities Focus Attention on Competition in Pharmaceutical Industry." Antitrust Update, Hogan & Hartson LLP

12.06.2007 "Issue Eight." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP

05.18.2007 "IRS Memorandum for Health IT Subsidies." Health Update, Hogan & Hartson LLP

05.02.2007 "Issue Six." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP

01.31.2007 "Issue Five." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP

PRACTICES/INDUSTRIES
Antitrust, Competition, and Consumer Protection
Health
Hospitals
Life Sciences
Antitrust Litigation
EDUCATION
J.D., Order of the Coif, University of California, Berkeley Boalt Hall School of Law, 1980 B.A., magna cum laude, Yale University, 1973
MEMBERSHIPS
  • Fellow, Past Vice President, and Member of the Board of Directors, American Health Lawyers Association
  • Co-chair, State Antitrust Enforcement Committee, Antitrust Section, American Bar Association
  • Former Chair, Health Care and Pharmaceuticals Committee, Antitrust Section, American Bar Association
AWARDS/RANKINGS
  • Washington, D.C. Super Lawyers, 2008
  • Chambers USA, Health Care, 2006-2007
  • Nightingale's Healthcare News, Outstanding Health Care Antitrust Lawyer, 2005
  • Guide to the Leading US Health Care Lawyers, 2005